title: In Vitro Enhanced Sensitivity to Cisplatin in D67Y BRCA1 RING Domain Protein.
abstract: BRCA1 is a tumor suppressor protein involved in maintaining genomic integrity through multiple functions in DNA damage repair, transcriptional regulation, cell cycle checkpoint, and protein ubiquitination. The BRCA1-BARD1 RING complex has an E3 ubiquitin ligase function that plays essential roles in response to DNA damage repair. BRCA1-associated cancers have been shown to confer a hypersensitivity to chemotherapeutic agents. Here, we have studied the functional consequence of the in vitro E3 ubiquitin ligase activity and cisplatin sensitivity of the missense mutation D67Y BRCA1 RING domain. The D67Y BRCA1 RING domain protein exhibited the reduced ubiquitination function, and was more susceptible to the drug than the D67E or wild-type BRCA1 RING domain protein. This evidence emphasized the potential of using the BRCA1 dysfunction as an important determinant of chemotherapy responses in breast cancer.
authors.affiliation: Laboratory of Pharmaceutical Biotechnology, Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat-Yai, Songkhla 90112, Thailand.
authors.forename: Apichart
authors.initials: A
authors.lastname: Atipairin
authors.forename: Adisorn
authors.initials: A
authors.lastname: Ratanaphan
references.citation: Exp Cell Res. 2004 Feb 1;293(1):14-21
references.pmid: 14729053
references.citation: J Biol Inorg Chem. 2011 Feb;16(2):217-26
references.pmid: 20967475
references.citation: Ann Oncol. 2008 Nov;19(11):1847-52
references.pmid: 18567607
references.citation: Ann Oncol. 2011 May;22(5):1127-1132
references.pmid: 21084428
references.citation: Breast Cancer Res Treat. 2011 Jul;128(2):301-13
references.pmid: 20686837
references.citation: Chem Biodivers. 2010 Aug;7(8):1949-67
references.pmid: 20730959
references.citation: Hum Mol Genet. 2004 Oct 15;13(20):2443-9
references.pmid: 15317748
references.citation: J Clin Oncol. 2010 Mar 1;28(7):1145-53
references.pmid: 20100965
references.citation: J Biol Chem. 2000 Aug 4;275(31):23899-903
references.pmid: 10843985
references.citation: BMC Pharmacol. 2011 Jul 19;11:7
references.pmid: 21771338
references.citation: Mol Cell Biol. 2010 Jun;30(11):2787-98
references.pmid: 20351172
references.citation: Cancer Res. 2010 Feb 1;70(3):988-95
references.pmid: 20103620
references.citation: Biochim Biophys Acta. 2006 Dec;1766(2):205-16
references.pmid: 16919882
references.citation: J Clin Oncol. 2010 Jan 20;28(3):375-9
references.pmid: 20008645
references.citation: Cancer Res. 2003 Oct 1;63(19):6221-8
references.pmid: 14559807
references.citation: Proc Natl Acad Sci U S A. 2003 May 13;100(10):5646-51
references.pmid: 12732733
references.citation: Cancer Sci. 2011 Apr;102(4):663-9
references.pmid: 21205087
references.citation: J Biol Chem. 2003 Feb 14;278(7):5255-63
references.pmid: 12431996
references.citation: Hum Mol Genet. 2006 Feb 15;15(4):599-606
references.pmid: 16403807
references.citation: Oncologist. 2007 Feb;12(2):142-50
references.pmid: 17296808
references.citation: Carcinogenesis. 2010 Jun;31(6):961-7
references.pmid: 20400477
references.citation: Int J Oncol. 2006 Dec;29(6):1397-404
references.pmid: 17088977
references.citation: Cell Signal. 2007 Sep;19(9):1879-92
references.pmid: 17531442
references.citation: Mol Cell. 2006 Mar 17;21(6):873-80
references.pmid: 16543155
references.citation: Cancer Res. 2005 Nov 1;65(21):10096-103
references.pmid: 16267036
references.citation: Cancer Chemother Pharmacol. 2008 May;61(6):965-71
references.pmid: 17639392
references.citation: Nat Rev Mol Cell Biol. 2010 Jul;11(7):479-89
references.pmid: 20551964
references.citation: Biochem Pharmacol. 2010 Sep 1;80(5):647-53
references.pmid: 20510205
references.citation: Breast Cancer Res Treat. 2011 Feb;125(3):627-36
references.pmid: 21161370
references.citation: Cancer Chemother Pharmacol. 2011 Sep;68(3):753-61
references.pmid: 21170648
references.citation: Nat Rev Clin Oncol. 2010 Dec;7(12):702-7
references.pmid: 20956982
references.citation: Ann Oncol. 2011 Jun;22(6):1346-1352
references.pmid: 21228333
references.citation: Nat Struct Biol. 2001 Oct;8(10):833-7
references.pmid: 11573085
references.citation: Hum Mutat. 2002 Sep;20(3):230
references.pmid: 12203997
references.citation: Ann Oncol. 2011 Jan;22(1):139-144
references.pmid: 20603439
references.citation: Ann Oncol. 2011 Jul;22(7):1561-1570
references.pmid: 21135055
references.citation: Mol Cell Biol. 2008 Dec;28(24):7380-93
references.pmid: 18936166
references.citation: Cancer Lett. 2007 Aug 8;253(1):131-7
references.pmid: 17321670
references.citation: Nat Rev Mol Cell Biol. 2010 Feb;11(2):138-48
references.pmid: 20029420
references.citation: Gynecol Oncol. 2009 Apr;113(1):134-42
references.pmid: 19168207
references.citation: EMBO J. 2002 Dec 16;21(24):6755-62
references.pmid: 12485996
references.citation: Cancer Biol Ther. 2009 Apr;8(7):648-53
references.pmid: 19333003
references.citation: Int J Mol Sci. 2009 Sep 24;10(9):4187-97
references.pmid: 19865540
references.citation: J Pathol. 2011 Jan;223(1):15-27
references.pmid: 20818641
references.citation: Breast Cancer Res Treat. 2009 May;115(2):359-63
references.pmid: 18649131
references.citation: Radiat Res. 2010 Jul;174(1):1-13
references.pmid: 20681793
references.citation: FEBS Lett. 2011 Sep 16;585(18):2836-44
references.pmid: 21570976
references.citation: Breast Cancer Res Treat. 2011 Feb;126(1):203-9
references.pmid: 20878461
references.citation: DNA Repair (Amst). 2010 Dec 10;9(12):1219-28
references.pmid: 21035408
references.citation: Cancer Biol Ther. 2006 Feb;5(2):137-41
references.pmid: 16479151
references.citation: Ann Oncol. 2010 Oct;21 Suppl 7:vii30-5
references.pmid: 20943632
references.citation: Cancer Res. 2010 Oct 15;70(20):7970-80
references.pmid: 20798217
references.citation: Cancer Genet Cytogenet. 2010 Feb;197(1):91-4
references.pmid: 20113845
references.citation: J Biol Chem. 2005 Feb 25;280(8):6993-7001
references.pmid: 15569676
references.citation: J Biol Chem. 2001 May 4;276(18):14537-40
references.pmid: 11278247
references.citation: Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5134-9
references.pmid: 11320250
references.citation: Br J Cancer. 2003 Apr 22;88(8):1285-91
references.pmid: 12698198